50 microgram matrix m adjuvant
chief executive officer novavax
chief executive officer sk bioscience
coronavirus spike s protein
country: unknown
novavax' recombinantnanoparticletechnology
protein based vaccine candidate
saponin based matrix m adjuvant
stanley c erck president
two pivotal phase 3 trials